General Information of the Compound
| Compound ID |
CP0373437
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1H-Benzoimidazol-5-yl)-(1H-imidazol-2-yl)-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
(1H-Benzoimidazol-5-yl)-(1H-imidazol-2-yl)-amine
185312-13-4
1H-Benzimidazol-6-amine, N-1H-imidazol-2-yl-
AKOS027401219
BDBM50055831
CHEMBL74544
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C10H9N5
|
||||||||||||||||||
| Molecular Weight |
199.217
|
||||||||||||||||||
| Canonical SMILES |
N(c1ncc[nH]1)c1ccc2nc[nH]c2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C10H9N5/c1-2-8-9(14-6-13-8)5-7(1)15-10-11-3-4-12-10/h1-6H,(H,13,14)(H2,11,12,15)
Show/Hide
|
||||||||||||||||||
| InChIKey |
NFSIDEIKDWWMOX-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01650, Alpha-2A adrenergic receptor
Protein ID: PT03109, Alpha-2B adrenergic receptor
Protein ID: PT01598, Alpha-2C adrenergic receptor
Clinical Information about the Compound